The impact of side effects on long-term retention in three new antiepileptic drugs Hans P. Bootsma, Lukas Ricker, Yechiel A. Hekster, Jacques Hulsman, Danielle Lambrechts, Marian Majoie, Ad Schellekens, Marc de Krom, Albert P. Aldenkamp Seizure - European Journal of Epilepsy Volume 18, Issue 5, Pages 327-331 (June 2009) DOI: 10.1016/j.seizure.2008.11.006 Copyright © 2008 British Epilepsy Association Terms and Conditions
Fig. 1 Estimated retention rates by Kaplan–Meier survival analysis; comparison between LTG, LEV, and TPM. Seizure - European Journal of Epilepsy 2009 18, 327-331DOI: (10.1016/j.seizure.2008.11.006) Copyright © 2008 British Epilepsy Association Terms and Conditions
Fig. 2 Long-term seizure remission from baseline; comparison between LTG, LEV, and TPM. Seizure - European Journal of Epilepsy 2009 18, 327-331DOI: (10.1016/j.seizure.2008.11.006) Copyright © 2008 British Epilepsy Association Terms and Conditions
Fig. 3 Percentage of total study population in which adverse events played a role in drug discontinuation; comparison between LTG, LEV, and TPM. Seizure - European Journal of Epilepsy 2009 18, 327-331DOI: (10.1016/j.seizure.2008.11.006) Copyright © 2008 British Epilepsy Association Terms and Conditions